Health Care • Medical/Dental Instruments
$32.51 ▼ -0.35
(-1.06%)
MKT CAP: $1.09B • VOL: 125.4K
52W L $17 52W H $34
ROARABLE / RQD
D- • 41/100
PIOTROSKI
2 / 9
SGP // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 |
|---|---|---|
| Revenue (Total Sales) | $0 | $0 |
| YoY Revenue Growth % | — | — |
| Gross Profit | — | — |
| Gross Margin % | — | — |
| Research & Development (R&D) | — | — |
| Operating Income (EBIT) | -$41.4M | -$27.1M |
| Operating Margin % | — | — |
| Net Income (GAAP) | -$39.9M | -$29.2M |
| EBITDA (Normalized) | -$40.8M | -$25.5M |
| Diluted EPS ($/sh) | — | — |
| Operating Cash Flow (OCF) | -$32.7M | -$22.0M |
| Capital Expenditures (CapEx) | $789.0K | $2.0M |
| Free Cash Flow (FCF) | -$33.5M | -$24.0M |
| FCF Margin % | — | — |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% |
| Cash & Short-Term Equivalents | $96.4M | $16.3M |
| Total Debt (Short + Long Term) | — | — |
| Total Stockholders' Equity | -$98.8M | -$60.5M |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR SGP.